FOR LABORATORY RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION
◀ INDEXPEPPUDEX
PEG-MGF trading card

NO. 037 · STAGE 1 · Lv. 72 · HP 135

PEG-MGF

PEGylated Mechano Growth Factor · IGF-1Ec

REVIEWED BY · PEPPU STUDIO RESEARCH DESK·LAST UPDATED · 2026-05-25
GROWTHREGEN

ALIASES

PEG-MGF, PEGylated MGF, mechano growth factor, IGF-1Ec, IGF-1Ec splice variant

CLASS

Synthetic peptide · PEGylated IGF-1 Ec splice variant

FORMULA

C121H200N42O39 (24-residue core, plus PEG conjugate)

SEQUENCE

C-terminal Ec exon: YQPPSTNKNTKSQRRKGSTFEERK (24 residues, PEGylated)

HALF-LIFE

Several days (PEGylated vs. <30 minutes for native MGF)

ROUTES

Subcutaneous (research) · Intramuscular (research)

MECHANISM OF ACTION

PEGylated form of mechano growth factor (MGF), the IGF-1Ec splice variant produced locally in muscle in response to mechanical loading or injury. Drives satellite cell activation, proliferation, and local hypertrophy. PEG conjugation extends the otherwise sub-hour half-life to support practical research dosing.

EVIDENCE GRADES

Satellite-cell activation (in vitro / animal)B

Goldspink and Hill multi-paper evidence base for MGF-induced satellite cell activation and local hypertrophy after mechanical loading.

Local muscle hypertrophy (animal)B

Intramuscular MGF injections produce local hypertrophy in rodent and rabbit models.

Long-term human outcomesD

No completed long-term human Phase 3 trials.

MECHANISM CATEGORIES

RESEARCH CONDITIONS

SAFETY

Side effects

  • Injection-site reactions
  • Local swelling/redness with IM administration
  • Limited published Western safety data
  • Theoretical hypoglycemia (IGF-1R activation)

Known interactions

  • Insulin / glucose-lowering agents (theoretical hypoglycemia risk via IGF-1R)
  • Concurrent rhGH not recommended

Contraindications

  • Active malignancy
  • Pregnancy/lactation
  • Diabetic retinopathy

REGULATORY STATUS

FDA · Not FDA-approved. Research-use only.

WADA · Prohibited at all times under WADA Section S2 (Growth Factors sub-category).

STORAGE

Lyophilized · -20 °C 24 months

Reconstituted · 2-8 °C, 14-28 days

PEER-REVIEWED EVIDENCE

  • Goldspink G, Yang SY. Mechano growth factor and a method for improvement of muscle. J Musculoskelet Neuronal Interact 2002. link →
  • Hill M, Wernig A, Goldspink G. Muscle satellite (stem) cell activation during local tissue injury and repair. J Anat 2003. link →

FAQ · 8 QUESTIONS

What is PEG-MGF?

PEG-MGF is a PEGylated form of mechano growth factor (MGF), the IGF-1Ec splice variant produced locally in muscle in response to mechanical loading or injury. PEGylation extends the otherwise sub-30-minute half-life to support practical research dosing.

What is MGF?

Mechano Growth Factor (MGF) is a splice variant of IGF-1 with an alternative C-terminal Ec exon (vs the canonical Ea exon). It is produced locally in skeletal muscle in response to mechanical loading or injury and drives satellite-cell activation, proliferation, and local hypertrophy. The Ec peptide acts independently of the IGF-1Ea mature peptide.

PEG-MGF vs IGF-1 LR3 · which is better?

Different mechanisms. IGF-1 LR3 is a systemic IGF-1R agonist that drives whole-body anabolism. PEG-MGF acts more locally on satellite-cell activation at the site of injection or injury and does not produce the same systemic IGF-1R signaling. Research protocols select between them based on the local-vs-systemic research design.

Is PEG-MGF FDA-approved?

No. Research-use only.

Is PEG-MGF WADA-prohibited?

Yes. PEG-MGF is prohibited at all times under WADA Section S2 in the Growth Factors sub-category.

What is the half-life of PEG-MGF?

Several days, depending on the PEG conjugate. Native MGF has a half-life under 30 minutes; the PEGylation strategy extends systemic exposure to support practical dosing in animal-model research.

How is PEG-MGF dosed in research?

Animal-model and community-reported research protocols use 200-1000 mcg per administration, subcutaneous or intramuscular at the target muscle, post-workout in resistance-training research. No human dose is recommended by this wiki.

Why is PEG-MGF injected locally?

MGF is the local IGF-1 variant produced in response to muscle loading. Local intramuscular injection at the target muscle group is the standard research approach to maximize satellite-cell activation at that specific site rather than driving systemic IGF-1R signaling.

SIGNATURE MOVES

Satellite Cell CallPOW 60

Activates muscle satellite cells. Local hypertrophy signal.

PEG LockPOW 90

Extended half-life vs native MGF. Stable systemic exposure.

SOURCED FROM PEPPU LABS

Reference compounds documented on this page are available as research-grade material at Peppu Studio · ≥99% purity · per-batch Certificate of Analysis. For laboratory research use only. No human dose is recommended by this wiki.

SOURCE AT PEPPU LABS ▶WIKI ENTRY ▶

▶ LAST UPDATED · 2026-05-25

© 2026 Peppu Studio LLC · For Laboratory Research Use Only